{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:20:16Z","timestamp":1784830816712,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,21]]},"DOI":"10.7759\/cureus.76164","type":"journal-article","created":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T05:32:09Z","timestamp":1734845529000},"source":"Crossref","is-referenced-by-count":3,"title":["Romiplostim Reduces Platelet Transfusion Needs in Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation"],"prefix":"10.7759","author":[{"given":"Vadlamani","family":"Surya Prakash","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh R","family":"Nair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharmesh","family":"Soneji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Thareja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj P","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyotindu","family":"Debnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurjeet Singh","family":"Chowdhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhupesh","family":"Guleria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neerja","family":"Kushwaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rama","family":"H","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Bohra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harshit","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeevan","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kundan","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study","volume":"380","author":"Wandt H","year":"2012","unstructured":"Wandt H, Schaefer-Eckart K, Wendelin K, et al.. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet. 2012, 380:1309-16. 10.1016\/S0140-6736(12)60689-8","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth SJ","year":"2013","unstructured":"Stanworth SJ, Estcourt LJ, Powter G, et al.. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med. 2013, 368:1771-80. 10.1056\/NEJMoa1212772","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-118372","article-title":"A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation","volume":"112","author":"Gajewski JL","year":"2008","unstructured":"Gajewski JL, Johnson VV, Sandler SG, Sayegh A, Klumpp TR. A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation. Blood. 2008, 112:3036-47. 10.1182\/blood-2007-10-118372","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline update","volume":"36","author":"Schiffer CA","year":"2018","unstructured":"Schiffer CA, Bohlke K, Delaney M, et al.. Platelet transfusion for patients with cancer: American Society of Clinical Oncology Clinical Practice Guideline update. J Clin Oncol. 2018, 36:283-99. 10.1200\/JCO.2017.76.1734","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12791","article-title":"Transfusion-related adverse events in the platelet dose study","volume":"55","author":"Kaufman RM","year":"2015","unstructured":"Kaufman RM, Assmann SF, Triulzi DJ, Strauss RG, Ness P, Granger S, Slichter SJ. Transfusion-related adverse events in the platelet dose study. Transfusion. 2015, 55:144-53. 10.1111\/trf.12791","journal-title":"Transfusion"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1701464","article-title":"Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation","volume":"22","author":"Gordon B","year":"1998","unstructured":"Gordon B, Tarantolo S, Ruby E, Stephens L, Lynch J, Kessinger A, Haire W. Increased platelet transfusion requirement is associated with multiple organ dysfunctions in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 1998, 22:999-1003. 10.1038\/sj.bmt.1701464","journal-title":"Bone Marrow Transplant"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-680744","article-title":"Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients","volume":"127","author":"Claushuis TA","year":"2016","unstructured":"Claushuis TA, van Vught LA, Scicluna BP, et al.. Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood. 2016, 127:3062-72. 10.1182\/blood-2015-11-680744","journal-title":"Blood"},{"key":"ref8","unstructured":"NPLATE\u00ae (romiplostim) for injection, for subcutaneous use. Highlights of prescribing information. (2008). Accessed. June 5, 2024: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2022\/125268s172lbl.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-013-2074-2","article-title":"Romiplostim for management of chemotherapy-induced thrombocytopenia","volume":"22","author":"Parameswaran R","year":"2014","unstructured":"Parameswaran R, Lunning M, Mantha S, Devlin S, Hamilton A, Schwartz G, Soff G. Romiplostim for management of chemotherapy-induced thrombocytopenia. Support Care Cancer. 2014, 22:1217-22. 10.1007\/s00520-013-2074-2","journal-title":"Support Care Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2021.1924053","article-title":"Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia","volume":"14","author":"Al-Samkari H","year":"2021","unstructured":"Al-Samkari H, Soff GA. Clinical challenges and promising therapies for chemotherapy-induced thrombocytopenia. Expert Rev Hematol. 2021, 14:437-48. 10.1080\/17474086.2021.1924053","journal-title":"Expert Rev Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2020.251900","article-title":"A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies","volume":"106","author":"Al-Samkari H","year":"2021","unstructured":"Al-Samkari H, Parnes AD, Goodarzi K, Weitzman JI, Connors JM, Kuter DJ. A multicenter study of romiplostim for chemotherapy-induced thrombocytopenia in solid tumors and hematologic malignancies. Haematologica. 2021, 106:1148-57. 10.3324\/haematol.2020.251900","journal-title":"Haematologica"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01931","article-title":"Romiplostim treatment of chemotherapy-induced thrombocytopenia","volume":"37","author":"Soff GA","year":"2019","unstructured":"Soff GA, Miao Y, Bendheim G, et al.. Romiplostim treatment of chemotherapy-induced thrombocytopenia. J Clin Oncol. 2019, 37:2892-8. 10.1200\/JCO.18.01931","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007838","article-title":"Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation","volume":"7","author":"Scordo M","year":"2023","unstructured":"Scordo M, Gilbert LJ, Hanley DM, et al.. Open-label pilot study of romiplostim for thrombocytopenia after autologous hematopoietic cell transplantation. Blood Adv. 2023, 7:1536-44. 10.1182\/bloodadvances.2022007838","journal-title":"Blood Adv"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.3488","article-title":"Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline update","volume":"33","author":"Smith TJ","year":"2015","unstructured":"Smith TJ, Bohlke K, Lyman GH, et al.. Recommendations for the use of WBC growth factors: American Society of Clinical Oncology Clinical Practice Guideline update. J Clin Oncol. 2015, 33:3199-212. 10.1200\/JCO.2015.62.3488","journal-title":"J Clin Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hemonc.2018.11.003","article-title":"A single-institution experience of performing bloodless transplant in Jehovah's Witness patients","volume":"12","author":"Coltoff A","year":"2019","unstructured":"Coltoff A, Shreenivas A, Afshar S, Steinberg A. A single-institution experience of performing bloodless transplant in Jehovah's Witness patients. Hematol Oncol Stem Cell Ther. 2019, 12:44-9. 10.1016\/j.hemonc.2018.11.003","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12284","article-title":"Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support","volume":"161","author":"Al-Nawakil C","year":"2013","unstructured":"Al-Nawakil C, Quarre MC, Heshmati F, et al.. Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support. Br J Haematol. 2013, 161:738-40. 10.1111\/bjh.12284","journal-title":"Br J Haematol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.180166","article-title":"The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors","volume":"103","author":"Al-Samkari H","year":"2018","unstructured":"Al-Samkari H, Marshall AL, Goodarzi K, Kuter DJ. The use of romiplostim in treating chemotherapy-induced thrombocytopenia in patients with solid tumors. Haematologica. 2018, 103:e169-72. 10.3324\/haematol.2017.180166","journal-title":"Haematologica"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11102859","article-title":"Blood transfusion reactions-a comprehensive review of the literature including a Swiss perspective","volume":"11","author":"Ackfeld T","year":"2022","unstructured":"Ackfeld T, Schmutz T, Guechi Y, Le Terrier C. Blood transfusion reactions-a comprehensive review of the literature including a Swiss perspective. J Clin Med. 2022, 11:2859. 10.3390\/jcm11102859","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.308","article-title":"Venous thromboembolism in hematopoietic stem cell transplant recipients","volume":"51","author":"Chaturvedi S","year":"2016","unstructured":"Chaturvedi S, Neff A, Nagler A, Savani U, Mohty M, Savani BN. Venous thromboembolism in hematopoietic stem cell transplant recipients. Bone Marrow Transplant. 2016, 51:473-8. 10.1038\/bmt.2015.308","journal-title":"Bone Marrow Transplant"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020004167","article-title":"Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma","volume":"5","author":"Dahi PB","year":"2021","unstructured":"Dahi PB, Lee J, Devlin SM, et al.. Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma. Blood Adv. 2021, 5:2608-18. 10.1182\/bloodadvances.2020004167","journal-title":"Blood Adv"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/276777-romiplostim-reduces-platelet-transfusion-needs-in-multiple-myeloma-patients-undergoing-autologous-stem-cell-transplantation","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T05:32:11Z","timestamp":1734845531000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/276777-romiplostim-reduces-platelet-transfusion-needs-in-multiple-myeloma-patients-undergoing-autologous-stem-cell-transplantation"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,21]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.76164","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,21]]}}}